Skip to main
GOCO
GOCO logo

GoHealth, Inc. (GOCO) Stock Forecast & Price Target

GoHealth, Inc. (GOCO) Analyst Ratings

Based on 10 analyst ratings
Hold
Strong Buy 10%
Buy 20%
Hold 50%
Sell 20%
Strong Sell 0%

Bulls say

GoHealth Inc. has recently demonstrated stabilized membership persistency and lifetime value (LTV), indicating a more rationalized approach to marketing spend within the industry. The company anticipates flat year-over-year revenue while benefiting from expected growth in submission volume aligned with the broader Medicare market, suggesting healthy operating conditions. Furthermore, an upgraded adjusted EBITDA estimate for 2025 to $100.9 million reflects confidence in the performance of the Encompass platform, which enhances revenue and cash flow visibility without the implications of ASC-606 accounting.

Bears say

GoHealth is experiencing diminished topline visibility, evidenced by a fourth-quarter revenue miss, leading to a downward revision of its 2024 revenue estimate from $765.6 million to $741.7 million. The company faces significant headwinds related to persistency that are expected to result in negative tail-revenue and lower cash received from commissions, with adjusted EBITDA forecasts reflecting declines of approximately 15% to 20% from base case estimates. Additionally, various risks—including growing competition, dependence on a limited number of carrier partners, and increasing customer churn—further contribute to a negative outlook for the company's financial performance.

GoHealth, Inc. (GOCO) has been analyzed by 10 analysts, with a consensus rating of Hold. 10% of analysts recommend a Strong Buy, 20% recommend Buy, 50% suggest Holding, 20% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GoHealth, Inc. and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GoHealth, Inc. (GOCO) Forecast

Analysts have given GoHealth, Inc. (GOCO) a Hold based on their latest research and market trends.

According to 10 analysts, GoHealth, Inc. (GOCO) has a Hold consensus rating as of Jul 3, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.08, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.08, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GoHealth, Inc. (GOCO)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.